Abstract
Flexible endoscopic full-thickness suturing is being performed for a variety of clinical indications. The OverStitch (Apollo Endosurgery, Austin, Tex, USA) is currently the only such device approved by the U.S. Food and Drug Administration (Fig. 1). This device is being increasingly used to anchor stents within the GI lumen, perform primary and revisional bariatric procedures, and approximate tissue defects. This platform allows one to perform both interrupted and running suture patterns using either absorbable or nonabsorbable sutures.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
